What You Should Know:
- Sibel Health has recently closed a $33M Series B financing round, bringing Sibel's total funding to date to more than $50M.
- In addition, Sibel has announced two new executive appointments. Jon Otterstatter, the former CEO and co-founder of Preventice (acquired by Boston Scientific in 2021), will join as chairman of the board. Matthew Banet, Ph.D., a world expert in advanced body-worn sensors and previously the CTO and co-founder of toSense and Sotera, joins as
Read More
Cardiac Monitoring
Biotricity Awarded FDA 510(k) Clearance for Cardiac Monitoring Device
What You Should Know:
- Biotricity, Inc. (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology company, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Biotres Cardiac Monitoring Device, a three-lead device for ECG and arrhythmia monitoring that is intended for lower-risk patients.
- Most remote cardiac monitors are passive — they don’t record ECG and other cardiac data in real-time — and lack cross-compatibility
Read More
Philips Acquires Cardiologs to Expand Cardiac Diagnostics & Monitoring Portfolio
What You Should Know:
- Philips today announced that it has signed an agreement to acquire Paris-based Cardiologs, a France-based medical technology company focused on transforming cardiac diagnostics using artificial intelligence (AI) and cloud technology.
- Cardiologs will further strengthen Philips’ cardiac monitoring and diagnostics offering with innovative software technology, electrocardiogram (ECG) analysis and reporting services. Financial details of the acquisition were not
Read More
Eko Launches Next Generation DUO ECG + Digital Stethoscope for Frontline Clinicians
What You Should Know:
- Eko, a cardiopulmonary digital health company launches its next-generation Eko DUO, an FDA-cleared cardiac assessment tool that functions as an electrocardiogram (ECG) and digital stethoscope to detect early signs of heart disease and facilitate timely care and personalized disease management.
- DUO is a pocket-sized cardiac examination system for clinicians used to detect early signs of heart disease and facilitate timely care for patients in and out of the clinic.
Read More
Ultromics Raises $33M for AI-Enabled Echocardiograms to Help Clinicians Diagnose Heart Disease
What You Should Know:
- Today, Ultromics, an Oxford, England-based health-tech startup announced it has raised $33M in Series B funding led by Blue Ventures, the investing arm of Blue Cross Blue Shield, and also includes investment from Optum Ventures, GV, and Oxford Sciences.
- Born at the University of Oxford and built-in partnership with the U.K.’s NHS, Ultromics has developed the first fully automated solution for echocardiography and analysis of global longitudinal strain (GLS).
Read More
Medtronic Awarded FDA Clearance for 2 AI Algorithms for Cardiac Monitoring
What You Should Know:
- Medtronic announced U.S. Food and Drug Administration (FDA) clearance for two AccuRhythm™ AI algorithms for use with the LINQ II™ insertable cardiac monitor (ICM) – and the presentation of AccuRhythm AI validation data this week at Heart Rhythm 2021.
- AccuRhythm AI applies artificial intelligence (AI) to heart rhythm event data collected by LINQ II, improving the accuracy of information physicians receive so they can better diagnose and treat abnormal heart
Read More
Could ‘Hospitals Without Walls’ Be the New Normal for Telehealth and Remote Patient Monitoring?
The statistics surrounding the COVID-19 pandemic continue to be startling, despite the ever-growing mental and physical fatigue that we’ve all experienced living through this frightening, intimidating and unprecedented era. More than 125 million cases worldwide have resulted in a death toll closing in on three million, while in the United States alone, 30 million reported infections have resulted in a death toll that reached 550,000. (1) One thing that can be said for certain about
Read More
The Future of Remote Care Automation Begins with Cardiac Rehabilitation
2020 was undeniably the year that saw telehealth and remote care services come to the forefront of medical care. Many have hypothesized that, in the post-COVID world, remote care programs will be ubiquitous throughout hospitals and health systems. However, such a future is far from certain, as too many organizations currently lack the budget, IT infrastructure, and time necessary to implement new innovative remote care programs. There is a considerable disparity between the hype surrounding
Read More
How Will Philips Acquisition of BioTelemetry Impact The Cardiac Monitoring Market?
At the end of December 2020, Philips announced the planned acquisition of BioTelemetry for $2.8 billion in cash.
- BioTelemetry was formed in 2013 after a series of acquisitions from the initial founding company CardioNet, Inc.
- CardioNet, Inc. based in San Diego, USA was initially founded in 1994.
- After a multitude of acquisitions in recent years, BioTelemetry has established itself as a leading cardiac powerhouse, specializing in mobile and wireless medical technology. After this
Read More
Casana Raises $14M to Expand IoT Heart Health Toilet Seat
What You Should Know:
- Casana raises $14M in Series A funding to pursue FDA clearance for its an IoT heart health toilet seat that captures clinically relevant measurements, including heart rate, blood pressure, blood oxygenation, and cardiac output.
Casana, previously known as Heart Health Intelligence, Inc., a healthcare technology firm that is re-inventing in-home health monitoring, today announced that it has raised $14M in Series A funding, bringing the total capital raised to
Read More
